Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
04 03 2021
Historique:
received: 31 10 2020
accepted: 09 02 2021
revised: 08 02 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 14 9 2021
Statut: epublish

Résumé

Pseudomonas aeruginosa is a common respiratory pathogen in cystic fibrosis (CF) patients which undergoes adaptations during chronic infection towards reduced virulence, which can facilitate bacterial evasion of killing by host cells. However, inflammatory cytokines are often found to be elevated in CF patients, and it is unknown how chronic P. aeruginosa infection can be paradoxically associated with both diminished virulence in vitro and increased inflammation and disease progression. Thus, we investigated the relationship between the stimulation of inflammatory cell death pathways by CF P. aeruginosa respiratory isolates and the expression of key inflammatory cytokines. We show that early respiratory isolates of P. aeruginosa from CF patients potently induce inflammasome signaling, cell death, and expression of IL-1β by macrophages, yet little expression of other inflammatory cytokines (TNF, IL-6 and IL-8). In contrast, chronic P. aeruginosa isolates induce relatively poor macrophage inflammasome signaling, cell death, and IL-1β expression but paradoxically excessive production of TNF, IL-6 and IL-8 compared to early P. aeruginosa isolates. Using various mutants of P. aeruginosa, we show that the premature cell death of macrophages caused by virulent bacteria compromises their ability to express cytokines. Contrary to the belief that chronic P. aeruginosa isolates are less pathogenic, we reveal that infections with chronic P. aeruginosa isolates result in increased cytokine induction due to their failure to induce immune cell death, which results in a relatively intense inflammation compared with early isolates.

Identifiants

pubmed: 33664232
doi: 10.1038/s41419-021-03526-w
pii: 10.1038/s41419-021-03526-w
pmc: PMC7933143
doi:

Substances chimiques

Cytokines 0
Inflammasomes 0
Inflammation Mediators 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
NLRP3 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

241

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK089507
Pays : United States

Références

Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):914-21
pubmed: 2109558
J Infect Dis. 2013 May 15;207(10):1544-55
pubmed: 23402824
Cell Physiol Biochem. 2016;40(5):1063-1078
pubmed: 27960153
Am J Respir Crit Care Med. 2003 Dec 15;168(12):1471-5
pubmed: 12969869
Nat Rev Rheumatol. 2016 Jan;12(1):49-62
pubmed: 26656660
Mol Microbiol. 1997 Aug;25(3):547-57
pubmed: 9302017
Infect Immun. 2010 Jul;78(7):2937-45
pubmed: 20457788
Immunity. 2017 Dec 19;47(6):1169-1181.e7
pubmed: 29246444
PLoS One. 2012;7(5):e37689
pubmed: 22649552
Am J Respir Crit Care Med. 1994 Aug;150(2):448-54
pubmed: 8049828
Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2111-8
pubmed: 8520783
Discov Med. 2010 Apr;9(47):346-56
pubmed: 20423679
J Med Microbiol. 2018 Aug;67(8):1191-1201
pubmed: 30067169
FASEB J. 2019 Jun;33(6):7437-7450
pubmed: 30869997
Front Immunol. 2018 Oct 22;9:2416
pubmed: 30405616
Immunobiology. 2009;214(7):543-53
pubmed: 19250700
Pediatr Pulmonol. 1996 Jan;21(1):11-9
pubmed: 8776260
Infect Immun. 2005 Apr;73(4):1907-16
pubmed: 15784530
Infect Immun. 1985 Nov;50(2):577-82
pubmed: 3932214
Pathogens. 2015 Mar 02;4(1):66-89
pubmed: 25738646
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2833-8
pubmed: 16477005
J Cyst Fibros. 2018 May;17(3):341-347
pubmed: 29110966
Pathogens. 2014 Apr 10;3(2):309-40
pubmed: 25437802
Eur Respir J. 2010 Aug;36(2):311-22
pubmed: 20110398
Cytokine Growth Factor Rev. 2011 Aug;22(4):189-95
pubmed: 22019906
Scand J Infect Dis. 2000;32(1):75-9
pubmed: 10716082
Am J Respir Crit Care Med. 2011 Jul 1;184(1):75-81
pubmed: 21493738
Eur Respir J. 1999 Aug;14(2):339-46
pubmed: 10515411
Pediatr Pulmonol. 2005 Jul;40(1):15-21
pubmed: 15858808
Pediatr Res. 1993 Aug;34(2):159-61
pubmed: 8233718
Immunol Rev. 2011 Sep;243(1):174-90
pubmed: 21884176
Breathe (Sheff). 2018 Jun;14(2):87-90
pubmed: 29877519
Eur J Immunol. 2010 Dec;40(12):3528-34
pubmed: 21072873
J Cyst Fibros. 2004 Dec;3(4):223-31
pubmed: 15698939
Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1371-87
pubmed: 16950166
Nat Rev Microbiol. 2012 Dec;10(12):841-51
pubmed: 23147702
Clin Infect Dis. 2013 Aug;57(3):384-91
pubmed: 23625938
J Biol Chem. 2010 Jul 16;285(29):22299-307
pubmed: 20460375
J Cyst Fibros. 2015 Jul;14(4):419-30
pubmed: 25814049
J Clin Microbiol. 2004 Nov;42(11):5229-37
pubmed: 15528719
Nat Commun. 2015 Feb 18;6:6282
pubmed: 25693118
Front Pharmacol. 2011 Aug 23;2:48
pubmed: 21897819
Transl Res. 2008 Dec;152(6):257-64
pubmed: 19059160
J Leukoc Biol. 2011 Mar;89(3):481-8
pubmed: 21178113
J Pediatr. 1988 Apr;112(4):547-54
pubmed: 3127569
J Immunol. 2016 Apr 1;196(7):3097-108
pubmed: 26895832
J Immunol. 2009 Jul 15;183(2):787-91
pubmed: 19570822
Eur Respir J. 2014 Jan;43(1):125-33
pubmed: 23598952
Nature. 2011 Oct 16;479(7371):117-21
pubmed: 22002608
Cell Death Discov. 2018 Jun 27;4:3
pubmed: 30062052
J Gen Microbiol. 1955 Dec;13(3):572-81
pubmed: 13278508
J Biol Chem. 2018 Jul 27;293(30):11913-11927
pubmed: 29899110
J Bacteriol. 1999 Dec;181(23):7401-4
pubmed: 10572149
Nat Chem Biol. 2019 Jun;15(6):556-559
pubmed: 31086327
Cold Spring Harb Perspect Biol. 2015 Apr 01;7(4):
pubmed: 25833847
J Clin Invest. 1989 Oct;84(4):1045-9
pubmed: 2677047
J Cyst Fibros. 2012 Sep;11(5):363-82
pubmed: 22917571
Infect Immun. 2005 Oct;73(10):6822-30
pubmed: 16177360

Auteurs

Melissa S Phuong (MS)

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Rafael E Hernandez (RE)

Center for Global Infectious Diseases Research, Seattle Children's Research Institute, Seattle, WA, USA.
Department of Pediatrics, University of Washington, Seattle, WA, USA.

Daniel J Wolter (DJ)

Department of Pediatrics, University of Washington, Seattle, WA, USA.

Lucas R Hoffman (LR)

Department of Pediatrics, University of Washington, Seattle, WA, USA.
Department of Microbiology, University of Washington, Seattle, WA, USA.

Subash Sad (S)

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. Subash.sad@uottawa.ca.
University of Ottawa Centre for Infection, Immunity and Inflammation (CI3), Ottawa, ON, Canada. Subash.sad@uottawa.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH